跳至主要内容
临床试验/ChiCTR2200067014
ChiCTR2200067014尚未招募2 期

The Clinical Effectiveness of Virtual-Reality (VR) Assisted Tai Chi in Chronic Musculoskeletal Pain: A Randomized Clinical Trial

There was no funding support for this study.1 个研究点 分布在 1 个国家开始时间: 2022年12月26日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
试验地点
1
主要终点
簡易疼痛量表 - 疼痛程度

研究概览

简要总结

Primary Aim: To assess the clinical effectiveness of VR assisted Tai Chi versus non-VR Tai Chi in adults with chronic MSK pain. Secondary aim: To assess the improvement in self-management of chronic pain, associated anxiety and depressive symptoms, and health-related quality of life.

研究设计

研究类型
Interventional
主要目的
随机平行对照
盲法
None

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • Participants aged 18 years or above with chronic musculoskeletal pain, defined as pain that lasted for more than 3 months persistently or intermittently, including regional pain (joints, limbs, back, and/or neck), a degenerative joint condition, such as osteoarthritis, and/or musculoskeletal complaints that fall under the chronic primary pain classification of the International Classification of Disease-11, pain intensity score >= 3 on a numerical rating scale of 10; stable baseline physical activity; and ability to understand written and verbal Chinese.

排除标准

  • Participants with cancer-related pain, inflammatory rheumatic disease; a recent history of stroke or major surgery in the past 6 months; terminal illness; serious mental illness; severe or uncontrolled heart disease; major joint replacement or spinal surgery; comorbid conditions that might impede active participation in the study.

研究组 & 干预措施

Group 1

Group 2

结局指标

主要结局

簡易疼痛量表 - 疼痛程度

时间窗: 第 0,8,12 週

國際身體活動問卷 - 短版

时间窗: 第 0,8,12 週

虛擬情境暈眩量表

时间窗: 第 0,8,12 週

次要结局

  • 健康問卷(第 0,8,12 週)
  • 疼痛自我效能問卷(第 0,8,12 週)
  • 焦慮自我評估量表(第 0,8,12 週)
  • 病人健康狀況量表(第 0,8,12 週)
  • 簡易疼痛量表- 日常生活干擾(第 0,8,12 週)
  • Sociodemographic data(第 0 週)

研究者

发起方
There was no funding support for this study.

研究点 (1)

Loading locations...

相似试验

The Clinical Effectiveness of Virtual-Reality (VR)... | 临床试验